BioCentury
ARTICLE | Clinical News

HspE7 plus Poly-ICLC: Interim Phase I data

March 31, 2008 7:00 AM UTC

Interim immunological data from the second, four-patient cohort enrolled in an open-label, U.S. Phase I trial showed that three patients had anti-HspE7 antibody responses and E7-specific T cell respon...